| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CMO &Head Of Development
1 company
Watkins Tim is a CMO &Head Of Development at Contineum Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $42K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | CTNM Contineum Therapeutics, Inc. | CMO &Head Of Development | Sale+OE | 3,611 | $15.02 | $54,220.25 | -100% | -11.9% | - | |
| Jan 28, 2026 | CTNM Contineum Therapeutics, Inc. | CMO &Head Of Development | Sale+OE | 3,611 | $14.18 | $51,188.25 | -81.7% | -13.1% | - | |
| Dec 29, 2025 | CTNM Contineum Therapeutics, Inc. | CMO &Head Of Development | Sale+OE | 3,611 | $12.06 | $43,558.41 | -100% | +3.2% | - |